Title
A Multidimensional Strategy To Detect Polypharmacological Targets In The Absence Of Structural And Sequence Homology
Abstract
Conventional drug design embraces the "one gene, one drug, one disease" philosophy. Polypharmacology, which focuses on multi-target drugs, has emerged as a new paradigm in drug discovery. The rational design of drugs that act via polypharmacological mechanisms can produce compounds that exhibit increased therapeutic potency and against which resistance is less likely to develop. Additionally, identifying multiple protein targets is also critical for side-effect prediction. One third of potential therapeutic compounds fail in clinical trials or are later removed from the market due to unacceptable side effects often caused by off-target binding. In the current work, we introduce a multidimensional strategy for the identification of secondary targets of known small-molecule inhibitors in the absence of global structural and sequence homology with the primary target protein. To demonstrate the utility of the strategy, we identify several targets of 4,5-dihydroxy-3-(1-naphthyldiazenyl)-2,7-naphthalenedisulfonic acid, a known micromolar inhibitor of Trypanosoma brucei RNA editing ligase 1. As it is capable of identifying potential secondary targets, the strategy described here may play a useful role in future efforts to reduce drug side effects and/or to increase polypharmacology.
Year
DOI
Venue
2010
10.1371/journal.pcbi.1000648
PLOS COMPUTATIONAL BIOLOGY
Keywords
Field
DocType
protein targeting,drug discovery,drug design,clinical trial,side effect,rna editing
Drug discovery,Gene targeting,Biology,RNA editing,Target protein,Sequence homology,Bioinformatics,Drug side effects,Drug,Rational design
Journal
Volume
Issue
ISSN
6
1
1553-7358
Citations 
PageRank 
References 
12
0.89
8
Authors
11
Name
Order
Citations
PageRank
Jacob D. Durrant11008.53
Rommie E Amaro211015.54
Lei Xie344139.48
Michael D. Urbaniak4171.32
Michael A. J. Ferguson5191.74
Antti Haapalainen6120.89
Zhijun Chen7120.89
Anne Marie Di Guilmi8120.89
Frank Wunder9120.89
Philip E. Bourne101995388.17
J. Andrew Mccammon1115616.58